Proteome Sciences plc

PRM.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue£4,887£5,028£23,736,000£22,593,000
% Growth-2.8%-100%5.1%
Cost of Goods Sold£4,217£3,381£3,013£2,169
Gross Profit£670£1,647£4,767£2,960
% Margin13.7%32.8%0%0%
R&D Expenses£606£637£376£287
G&A Expenses£3,023£3,268£2,642£2,335
SG&A Expenses£3,023£3,268£2,642£2,335
Sales & Mktg Exp.£0£0£0£0
Other Operating Expenses-£606-£637£21-£74
Operating Expenses£3,023£3,268£3,039£2,548
Operating Income-£2,353-£1,621£1,728£412
% Margin-48.1%-32.2%0%0%
Other Income/Exp. Net-£894-£797-£473-£294
Pre-Tax Income-£3,247-£2,418£1,255£118
Tax Expense£158£25-£70£46
Net Income-£3,406-£2,443£1,325£72
% Margin-69.7%-48.6%0%0%
EPS-0.012-0.0080.0050
% Growth-38.6%-284.4%2,150%
EPS Diluted-0.012-0.0080.0040
Weighted Avg Shares Out295,182294,373308,211361,809
Weighted Avg Shares Out Dil295,182295,182309,021301,851
Supplemental Information
Interest Income£0£0£0£0
Interest Expense£895£797£473£294
Depreciation & Amortization£837£484£397£213
EBITDA-£1,515-£1,137£2,125£625
% Margin-31%-22.6%0%0%